Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0001493152-24-052337·Insight Molecular Diagnostics Inc.
Schedule 13G ownership disclosure
ONCOCYTE CORPORATION
Common Stock, no par value · CUSIP: 68235C107
Event date: 2024-12-26
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Patrick W. Smith
Shares: 1,773,903.00 · Class: 10.5%
- PATRICK W SMITH TTEE THE SMITH IRREVOCABLE TRUST U/A DTD 05/01/2015
Shares: 1,773,903.00 · Class: 10.5%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001493152-24-052337
- Form type
- SCHEDULE 13G/A
- Filer
- Insight Molecular Diagnostics Inc.
- CIK
- CIK 1642380
- Filed
- Dec 27, 2024
- Reporting period
- Dec 26, 2024
- Description
- Schedule 13G beneficial ownership